StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible gross margin

Gross margin is gross profit as a percentage of revenue.

Skinvisible's gross margin for the twelve months ending Jun 30, 2026 was 100.0%. For fiscal 2025 it was 100.0%, against 100.0% the year before. The highest annual figure on record is 180.5% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025100.0%+0.0
FY2024Dec 31, 2024100.0%+0.0
FY2023Dec 31, 2023100.0%+1.7
FY2022Dec 31, 202298.3%−1.2
FY2021Dec 31, 202199.5%−81.0
FY2020Dec 31, 2020180.5%+119.6
FY2019Dec 31, 201960.9%−9.3
FY2018Dec 31, 201870.1%−23.1
FY2017Dec 31, 201793.3%+27.3
FY2016Dec 31, 201666.0%−1.4
FY2015Dec 31, 201567.4%+15.6
FY2014Dec 31, 201451.8%−45.0
FY2013Dec 31, 201396.7%−1.5
FY2012Dec 31, 201298.3%−0.8
FY2011Dec 31, 201199.1%+7.6
FY2010Dec 31, 201091.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026100.0%+0.0
Q1 FY2026Mar 31, 2026100.0%+0.0
Q4 FY2025Dec 31, 2025100.0%+0.0
Q3 FY2025Sep 30, 2025100.0%+0.0
Q2 FY2025Jun 30, 2025100.0%+0.0
Q1 FY2025Mar 31, 2025100.0%+0.0
Q4 FY2024Dec 31, 2024100.0%+0.0
Q3 FY2024Sep 30, 2024100.0%+0.0
Q2 FY2024Jun 30, 2024100.0%+0.0
Q1 FY2024Mar 31, 2024100.0%+0.0
Q4 FY2023Dec 31, 2023100.0%+0.0
Q3 FY2023Sep 30, 2023100.0%+35.4
Q2 FY2023Jun 30, 2023100.0%+0.0
Q1 FY2023Mar 31, 2023100.0%+0.0
Q4 FY2022Dec 31, 2022100.0%+0.0
Q3 FY2022Sep 30, 202264.6%−8.0
Q4 FY2021Dec 31, 2021100.0%−1.3
Q3 FY2021Sep 30, 2021100.0%−62.9
Q2 FY2021Jun 30, 2021100.0%−1233.0
Q1 FY2021Mar 31, 202172.6%−27.4
Q4 FY2020Dec 31, 2020101.3%+97.2
Q3 FY2020Sep 30, 2020162.9%+65.2
Q2 FY2020Jun 30, 20201333.0%+1284.3
Q1 FY2020Mar 31, 2020100.0%+4.5
Q4 FY2019Dec 31, 20194.0%−94.2
Q3 FY2019Sep 30, 201997.8%+16.8
Q2 FY2019Jun 30, 201948.7%−10.7
Q1 FY2019Mar 31, 201995.5%+45.9
Q4 FY2018Dec 31, 201898.2%−3.0
Q3 FY2018Sep 30, 201881.0%−10.9
Q2 FY2018Jun 30, 201859.4%+59.8
Q1 FY2018Mar 31, 201849.6%−37.9
Q4 FY2017Dec 31, 2017101.2%−36.0
Q3 FY2017Sep 30, 201791.9%+185.7
Q2 FY2017Jun 30, 2017-0.4%−75.8
Q1 FY2017Mar 31, 201787.5%–
Q4 FY2016Dec 31, 2016137.2%–
Q3 FY2016Sep 30, 2016-93.9%–
Q2 FY2016Jun 30, 201675.4%–

More Skinvisible figures

See a number that looks wrong?